Marjanka Schmidt

Our work spans the themes of precision medicine and survivorship. Our focus is on early detection and prevention of breast cancer and breast cancer recurrence; specifically, we aim to investigate germline genetic variants for their role in breast cancer subtype development and outcome. We strive to translate and implement our findings in models and tools to facilitate shared decision-making by patients and physicians with overarching goals to prevent breast cancer and recurrence of cancer, to reduce overtreatment, and to improve outcome. We also investigate and strive to implement the best Ethical, Legal, and Societal (ELSI) practices related to the (secondary) use of human data and materials.